Thanks for the advice.
I’m happy with my understanding of biotech. There are many many many bio’s, with supposed high caliber management and boards who never succeed. And it’s not for the lack of knowledge.
Back to that patient. They had a stem cell transplant in addition to CHM treatment. I’ll put their response in the bin and focus on the other patients responses. Underwhelming, imv.
All the best.
- Forums
- ASX - By Stock
- CHM
- Ann: CORE NK Platform Phase 1 Clinical Data Presentation
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: CORE NK Platform Phase 1 Clinical Data Presentation, page-46
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2757364 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 15260220 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2757364 | 0.004 |
43 | 28003271 | 0.003 |
15 | 13950505 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 15260220 | 25 |
0.006 | 13343479 | 16 |
0.007 | 3200000 | 3 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |